Ren Jinsheng, founder and chairman of Simcere Pharmaceutical Group, said during an event held in April that China has unique ...
An ad hoc committee will plan and host a 1.5-day public workshop to facilitate discussion focused on the translation of federal investments in biomedical science to innovation in drug development and ...
While biopharma’s overarching mission is to develop innovative medicines to improve patient outcomes, for these six people, ...
The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...
Triple click chemistry has revolutionized chemical synthesis with its simplicity and efficiency, allowing for the quick and selective assembly of complex molecules. Now, in a recent study, researchers ...
Beijing, June 11, 2026 - On this day, Bayer and Peking University (PKU) signed the fifth strategic collaboration agreement.
The number of therapies developed in China has doubled in recent years, and approximately one-third of the global licensing ...
Biotech stocks are rebounding as investors focus on innovative drug pipelines, clinical catalysts and improving funding ...
In this interview, NewsMedical speaks with Joanna Lipner, Co-Founder of PIKRALIDA, and Hanna Kierońska, Head of Drug Technology, about the company’s approach to reducing polypharmacy, drug formulation ...
Age-related macular degeneration (AMD) is the leading cause of vision loss in individuals over 65, characterized by abnormal changes in the macular, resulting in reduced vision and distorted objects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results